The December 4, 2000 issue of Signals Magazine, an online magazine of biotechnology industry analysis, features a guest column titled "Biotechnology: The Next Litigation Frontier" by Alston & Bird partner Liz Price. Ms. Price's article opens with a scenario in the "not too distant future" of a hastily called meeting between two of the world's top biotech companies to discuss mass tort litigation. As the scenario unfolds, it becomes apparent that the situation is not that far away from real life.
Ms. Price heads the firm's Biotechnology Products Liability Litigation Team. She concentrates her practice on trial work, with particular emphasis on toxic tort and product liability litigation.